ArticleMedComm2025

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling.

Yong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.